Financials (USD)
Sales 2024 * | 102M | Sales 2025 * | 114M | Capitalization | 222M |
---|---|---|---|---|---|
Net income 2024 * | -13M | Net income 2025 * | -11M | EV / Sales 2024 * | 2.19 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.95 x |
P/E ratio 2024 * |
-15.7
x | P/E ratio 2025 * |
-19.4
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 79.76% |
Latest transcript on OptimizeRx Corporation
Managers | Title | Age | Since |
---|---|---|---|
Will Febbo
CEO | Chief Executive Officer | 55 | 16-02-21 |
Edward Stelmakh
DFI | Director of Finance/CFO | 58 | 21-10-10 |
President | 46 | 19-04-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gregory Wasson
BRD | Director/Board Member | 65 | 20-07-20 |
Catherine Klema
BRD | Director/Board Member | 65 | Jan. 23 |
Patrick Spangler
BRD | Director/Board Member | 68 | 18-03-26 |
1st Jan change | Capi. | |
---|---|---|
+25.68% | 451B | |
+34.42% | 280B | |
+5.46% | 133B | |
+7.66% | 93.33B | |
+25.50% | 92.61B | |
+63.65% | 61.54B | |
+12.90% | 45.98B | |
+22.96% | 36.9B | |
-8.34% | 34.01B |